| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | The University of Texas John and Kathrine McGovern Medical School (MMS) | |||||||||||||||||||||||||
2 | Non-Degree Research Courses | |||||||||||||||||||||||||
3 | Non-degree Student: a student who is admitted to the school for one or more courses but not admitted to a degree program. Enrollment as a non-degree student does not entitle a student to admission to a degree program. A non-degree student is allowed to register only with the permission of the course instructor. Degree students may request a change in enrollment status to non-degree student. Reinstatement in the degree program will be considered at the discretion of the Admissions Committee. Non-degree status will expire after a two-year period of no activity in the program. For more information regarding the Clinical Research Curriculum, or to subscribe to the CRC distribution list to receive updates about upcoming courses, please email Deborah Garcia - Deborah.Garcia@uth.tmc.edu, CRC and MS Program Coordinator, or call our office at (713) 500-6708. | |||||||||||||||||||||||||
4 | https://med.uth.edu/crebm/clinical-research-education/clinical-research-curriculum/ | |||||||||||||||||||||||||
5 | Course Number | Course | Prerequisite | Description | Credit Hours | |||||||||||||||||||||
6 | CLRS 5001 | Introduction to Epidemiology Research | None | This course provides a basis for an understanding of the concepts and methodological skills necessary for designing and interpreting observational studies. These include validity (random error, bias and confounding), measures of disease occurrence and impact, measures of association, reliability and generalizability, causal inference, and critically reviewing evidence. | 1-1.5 sem. hrs. | |||||||||||||||||||||
7 | CLRS 5002 | Clinical Trial Design | None | This course prepares the student to design and analyze randomized trials of medical interventions. Covered topics include basic study design, recruitment, randomization, masking, data collection and quality control, participant adherence, sample size considerations, data monitoring and analysis, and meta- analysis. | 1-1.5 sem. hrs. | |||||||||||||||||||||
8 | CLRS 5004 | Research on Social and Behavioral Aspects of Clinical Research | None | This course will provide an overview of the role of social and behavioral factors in patient health outcomes, as well as an introduction to research methods specific to studying such factors. | 1 sem. hrs. | |||||||||||||||||||||
9 | CLRS 5005 | Healthcare Quality and Safety | None | This course begins with an overview of health services research. Subsequent classes will focus on either important topics within HSR or methods used in HSR; conceptualization of healthcare quality and safety; quality of care measurements; improvement science; and introductions to survey research and qualitative research. | 1 sem. hrs. | |||||||||||||||||||||
10 | CLRS 5009 | Biostatistics for Clinical Investigators | None | This course begins with an overview of descriptive statistics and provides students with the tools to perform univariate analyses using parametric and non-parametric methods for paired and unpaired designs. Emphasis is placed on choosing appropriate tests, evaluating assumptions for the tests, understanding the limitations of statistical tests, and appropriate interpretation of test results. Survival analysis and multiple regression techniques are introduced to familiarize the student with the availability and limitations of these tests. | 1.5 sem. hrs. | |||||||||||||||||||||
11 | CLRS 5011 | Literature Appraisal | None | In this course, the students will be expected to learn rules of evidence and demonstrate critical evaluation of the medical literature. Students will have an opportunity to demonstrate these concepts and skills by appraising the evidence in various areas of clinical research. This critical appraisal of existing evidence will be used to determine fruitful areas for new investigation. This course is run in small group sessions (6-12 students per group) to facilitate active participation and interaction. | 1 sem. hrs. | |||||||||||||||||||||
12 | CLRS 5012 | Ethical Aspects of Clinical Research | None | This course introduces the fundamental ethical principles of autonomy, beneficence, nonmaleficence, and justice and applies these principles to clinical research involving human subjects. The use of unproven therapies, the use of placebos, the consent process, institutional review board submission and review processes, conflict of interests, and the costs of clinical research are covered. | 1 sem. hrs. | |||||||||||||||||||||
13 | CLRS 5013 | Introduction to Translational Research | None | This course is an overview of the clinical research that bridges basic science and patient-based research. Topics include pharmaceutical research, genetic research, gene therapy, and genomics. | 1 sem. hrs. | |||||||||||||||||||||
14 | CLRS 5003 | Clinical Research Design Workshop | Consent of instructor | In this problem-based course, each student is expected to build a clinical research proposal in his/her field of interest. Each week, students are asked to present the appropriate parts of their protocols to facilitate the discussion of successive stages in study design. This course is run in small group sessions (6-14 students per group) to facilitate active participation and interaction. | 1.5 sem. hrs. | |||||||||||||||||||||
15 | CLRS 5014 | Translational Research Design Workshop | Consent of instructor | This workshop course provides a hands-on venue to introduce fundamentals of genetics, epigenetics, and gene expression profiling to clinicians. The goal is to provide clinical researchers with a good understanding of the high-throughput molecular technologies that are needed to conduct clinically relevant translational research. This course is run in a small group format (10 students) to facilitate active participation and interaction. | 1.5 sem. hrs. | |||||||||||||||||||||
16 | ||||||||||||||||||||||||||
17 | ||||||||||||||||||||||||||
18 | ||||||||||||||||||||||||||
19 | ||||||||||||||||||||||||||
20 | ||||||||||||||||||||||||||
21 | ||||||||||||||||||||||||||
22 | ||||||||||||||||||||||||||
23 | ||||||||||||||||||||||||||
24 | ||||||||||||||||||||||||||
25 | ||||||||||||||||||||||||||
26 | ||||||||||||||||||||||||||
27 | ||||||||||||||||||||||||||
28 | ||||||||||||||||||||||||||
29 | ||||||||||||||||||||||||||
30 | ||||||||||||||||||||||||||
31 | ||||||||||||||||||||||||||
32 | ||||||||||||||||||||||||||
33 | ||||||||||||||||||||||||||
34 | ||||||||||||||||||||||||||
35 | ||||||||||||||||||||||||||
36 | ||||||||||||||||||||||||||
37 | ||||||||||||||||||||||||||
38 | ||||||||||||||||||||||||||
39 | ||||||||||||||||||||||||||
40 | ||||||||||||||||||||||||||
41 | ||||||||||||||||||||||||||
42 | ||||||||||||||||||||||||||
43 | ||||||||||||||||||||||||||
44 | ||||||||||||||||||||||||||
45 | ||||||||||||||||||||||||||
46 | ||||||||||||||||||||||||||
47 | ||||||||||||||||||||||||||
48 | ||||||||||||||||||||||||||
49 | ||||||||||||||||||||||||||
50 | ||||||||||||||||||||||||||
51 | ||||||||||||||||||||||||||
52 | ||||||||||||||||||||||||||
53 | ||||||||||||||||||||||||||
54 | ||||||||||||||||||||||||||
55 | ||||||||||||||||||||||||||
56 | ||||||||||||||||||||||||||
57 | ||||||||||||||||||||||||||
58 | ||||||||||||||||||||||||||
59 | ||||||||||||||||||||||||||
60 | ||||||||||||||||||||||||||
61 | ||||||||||||||||||||||||||
62 | ||||||||||||||||||||||||||
63 | ||||||||||||||||||||||||||
64 | ||||||||||||||||||||||||||
65 | ||||||||||||||||||||||||||
66 | ||||||||||||||||||||||||||
67 | ||||||||||||||||||||||||||
68 | ||||||||||||||||||||||||||
69 | ||||||||||||||||||||||||||
70 | ||||||||||||||||||||||||||
71 | ||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||
73 | ||||||||||||||||||||||||||
74 | ||||||||||||||||||||||||||
75 | ||||||||||||||||||||||||||
76 | ||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||
78 | ||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||
80 | ||||||||||||||||||||||||||
81 | ||||||||||||||||||||||||||
82 | ||||||||||||||||||||||||||
83 | ||||||||||||||||||||||||||
84 | ||||||||||||||||||||||||||
85 | ||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||
87 | ||||||||||||||||||||||||||
88 | ||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||
90 | ||||||||||||||||||||||||||
91 | ||||||||||||||||||||||||||
92 | ||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||
94 | ||||||||||||||||||||||||||
95 | ||||||||||||||||||||||||||
96 | ||||||||||||||||||||||||||
97 | ||||||||||||||||||||||||||
98 | ||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||
100 | ||||||||||||||||||||||||||